PMH31 CATEGORICAL RESPONSE DEFINES TREATMENT EFFECTIVENESS OF OLANZAPINE VERSUS RISPERIDONE IN THE IMPROVEMENT OF NEGATIVE SYMPTOMS AND QUALITY OF LIFE IN SCHIZOPHRENIA
May 1, 2002, 00:00
10.1016/S1098-3015(10)61096-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)61096-0/fulltext
Title :
PMH31 CATEGORICAL RESPONSE DEFINES TREATMENT EFFECTIVENESS OF OLANZAPINE VERSUS RISPERIDONE IN THE IMPROVEMENT OF NEGATIVE SYMPTOMS AND QUALITY OF LIFE IN SCHIZOPHRENIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61096-0&doi=10.1016/S1098-3015(10)61096-0
First page :
Section Title :
Open access? :
No
Section Order :
284